- We remain positive on Riverstone (SGX:AP4)’s 2H24F outlook premised on the recovery of global semiconductor sales (July semiconductor sales spiked 19% y-o-y) as well as improving market dynamics within the healthcare gloves industry.
- - Read this at SGinvestors.io -
Industry dynamics remain positive.
- Current industry operating dynamics remain in favour of the local gloves manufacturers as customers are more receptive to the ASP increase. That said, industry blended ASP is set to improve further to US$21-22/1,000 pieces (pcs) by 4QCY24 as Malaysian glove makers are in the discussion stage to raise prices to translate the effect of the weakening US$ to customers. China glove makers’ ASPs now range at US$18-19/1,000 pcs from US$17-18 in the previous quarter.
- - Read this at SGinvestors.io -
- Meanwhile, prospects in the global semiconductor industry are expected to be driven by the increasing demand for generative artificial intelligence (AI), high-performance computing (HPC), and rapid advancement of the AI industry.
US tariff on China.
- Read more at SGinvestors.io.
Singapore Research RHB Securities Research | https://www.rhbgroup.com/ 2024-10-07
Previous report by RHB:
2024-08-07 Riverstone - Results In Line With Expectation; Maintain BUY.
Price targets by other brokers at Riverstone Target Prices.
Listing of research reports at Riverstone Analyst Reports.
Relevant links:
Riverstone Share Price History,
Riverstone Announcements,
Riverstone Dividends & Corporate Actions,
Riverstone News Articles
